İ. Çeli̇k

928 total citations
29 papers, 699 citations indexed

About

İ. Çeli̇k is a scholar working on Oncology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, İ. Çeli̇k has authored 29 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Epidemiology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in İ. Çeli̇k's work include Pancreatic and Hepatic Oncology Research (5 papers), Neuroendocrine Tumor Research Advances (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). İ. Çeli̇k is often cited by papers focused on Pancreatic and Hepatic Oncology Research (5 papers), Neuroendocrine Tumor Research Advances (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). İ. Çeli̇k collaborates with scholars based in Germany, United States and Sweden. İ. Çeli̇k's co-authors include Anja Wild, Peter Langer, Detlef K. Bartsch, Μ. Rothmund, C. Nies, Thomas Schilling, Brunhilde Chaloupka, Walter Fiedler, Johannes Nippgen and Jessica Hauschild and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

İ. Çeli̇k

28 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
İ. Çeli̇k Germany 13 320 225 195 133 105 29 699
Paul Van Slyke Canada 19 148 0.5× 181 0.8× 435 2.2× 87 0.7× 37 0.4× 32 966
Leslie Oleksowicz United States 17 236 0.7× 62 0.3× 138 0.7× 56 0.4× 59 0.6× 35 780
Kenji Inui Japan 17 197 0.6× 91 0.4× 311 1.6× 109 0.8× 32 0.3× 47 850
Robert Rzepko Poland 16 200 0.6× 165 0.7× 205 1.1× 69 0.5× 13 0.1× 44 711
Teiji Oda Japan 12 162 0.5× 130 0.6× 202 1.0× 23 0.2× 40 0.4× 52 736
Elsie Oppermann Germany 19 211 0.7× 166 0.7× 304 1.6× 30 0.2× 38 0.4× 58 997
Claudia Parisi Italy 18 342 1.1× 395 1.8× 193 1.0× 55 0.4× 28 0.3× 47 1.2k
Rosalie Veile United States 14 58 0.2× 88 0.4× 213 1.1× 66 0.5× 55 0.5× 32 647
Miguel Pericacho Spain 19 128 0.4× 54 0.2× 375 1.9× 34 0.3× 52 0.5× 47 944
Cheng Huang China 19 359 1.1× 91 0.4× 512 2.6× 64 0.5× 37 0.4× 84 1.1k

Countries citing papers authored by İ. Çeli̇k

Since Specialization
Citations

This map shows the geographic impact of İ. Çeli̇k's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by İ. Çeli̇k with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites İ. Çeli̇k more than expected).

Fields of papers citing papers by İ. Çeli̇k

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by İ. Çeli̇k. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by İ. Çeli̇k. The network helps show where İ. Çeli̇k may publish in the future.

Co-authorship network of co-authors of İ. Çeli̇k

This figure shows the co-authorship network connecting the top 25 collaborators of İ. Çeli̇k. A scholar is included among the top collaborators of İ. Çeli̇k based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with İ. Çeli̇k. İ. Çeli̇k is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Çeli̇k, İ., et al.. (2025). Radiological changes in anterior arm muscles after biceps long head tenotomy. Acta Radiologica. 66(7). 695–703.
2.
Cutsem, Eric Van, István Láng, Gunnar Folprecht, et al.. (2010). Cetuximab plus FOLFIRI: Final data from the CRYSTAL study on the association of KRAS and BRAF biomarker status with treatment outcome.. Journal of Clinical Oncology. 28(15_suppl). 3570–3570. 43 indexed citations
3.
Çeli̇k, İ., et al.. (2009). Year 2006 Surveillance Results of Hospital Acquired Infections in Firat University Hospital. DergiPark (Istanbul University). 1 indexed citations
4.
Tejpar, Sabine, Wendy De Roock, Bart Biesmans, et al.. (2008). Correlation of high amphiregulin and epiregulin expression in KRAS wild type colorectal primaries with response and survival benefit after treatment with cetuximab and irinotecan for metastatic disease.. Ghent University Academic Bibliography (Ghent University). 9 indexed citations
5.
Oliveira‐Ferrer, Leticia, Jessica Hauschild, Walter Fiedler, et al.. (2008). Cilengitide induces cellular detachment and apoptosis in endothelial and glioma cells mediated by inhibition of FAK/src/AKT pathway. Journal of Experimental & Clinical Cancer Research. 27(1). 86–86. 93 indexed citations
6.
Hassan, I., A. Wunderlich, E. P. Slater, et al.. (2006). Antisense p53 Decreases Production of VEGF in Follicular Thyroid Cancer Cells. Endocrine. 29(3). 409–412. 4 indexed citations
7.
Bauhofer, Artur, W. Lorenz, Michael Koller, et al.. (2006). Evaluation of the McPeek postoperative outcome score in three trials. Langenbeck s Archives of Surgery. 391(4). 418–427. 4 indexed citations
8.
Hoffmann, Sebastian, A. Ramaswamy, İ. Çeli̇k, et al.. (2006). Retinoic acid inhibits angiogenesis and tumor growth of thyroid cancer cells. Molecular and Cellular Endocrinology. 264(1-2). 74–81. 45 indexed citations
9.
Bauhofer, Artur, et al.. (2004). Effects of G-CSF and antibiotic prophylaxis in a 2�2 factorial design on outcome in septic rats. Inflammation Research. 53(S2). S126–9. 6 indexed citations
10.
Eberhart, Leopold, et al.. (2004). Kreuzvalidierung einfacher Messverfahren zur Ermittlung der Patientenzufriedenheit mit der anästhesiologischen Versorgung. AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie. 39(7). 406–411. 4 indexed citations
11.
Koller, Michael, H. Barth, İ. Çeli̇k, & Μ. Rothmund. (2004). A short history of Theoretical Surgery. Inflammation Research. 53(S2). S99–104. 1 indexed citations
12.
Wild, Anja, Annette Ramaswamy, Peter Langer, et al.. (2003). Frequent Methylation-Associated Silencing of theTissue Inhibitor of Metalloproteinase-3Gene in Pancreatic Endocrine Tumors. The Journal of Clinical Endocrinology & Metabolism. 88(3). 1367–1373. 65 indexed citations
13.
Duda, D., W. Lorenz, & İ. Çeli̇k. (2002). Histamine release in mesenteric traction syndrome during abdominal aortic aneurysm surgery: prophylaxis with H1 and H2 antihistamines. Inflammation Research. 51(10). 495–499. 11 indexed citations
14.
Wild, Anja, et al.. (2002). Chromosome 22q in pancreatic endocrine tumors: identification of a homozygous deletion and potential prognostic associations of allelic deletions. European Journal of Endocrinology. 147(4). 507–513. 30 indexed citations
15.
Çeli̇k, İ., et al.. (2001). Plasma histamine levels during plasmapheresis: difficult interpretation of adverse reactions to plasma substitutes. Inflammation Research. 50(2). 65–67. 59 indexed citations
16.
Çeli̇k, İ., et al.. (2001). Plasma histamine levels during plasmapheresis: difficult interpretation of adverse reactions to plasma substitutes. Inflammation Research. 50(S2). 65–67. 11 indexed citations
17.
18.
Bauhofer, Artur, et al.. (2001). Sickness behaviour, an animal equivalent to human quality of life, is improved in septic rats by G-CSF and antibiotic prophylaxis. Langenbeck s Archives of Surgery. 386(2). 132–140. 30 indexed citations
19.
Bartsch, Detlef K., Peter Langer, Anja Wild, et al.. (2000). Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: Surgery or surveillance?. Surgery. 128(6). 958–966. 112 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Van Slyke Breakdown of academic impact, for papers by Leslie Oleksowicz Breakdown of academic impact, for papers by Kenji Inui Breakdown of academic impact, for papers by Robert Rzepko Breakdown of academic impact, for papers by Teiji Oda Breakdown of academic impact, for papers by Elsie Oppermann Breakdown of academic impact, for papers by Claudia Parisi Breakdown of academic impact, for papers by Rosalie Veile Breakdown of academic impact, for papers by Miguel Pericacho Breakdown of academic impact, for papers by Cheng Huang
Rankless by CCL
2026